PMID: 11922957Mar 30, 2002Paper

Physiologically-based pharmacokinetic simulation modelling

Advanced Drug Delivery Reviews
G M Grass, P J Sinko

Abstract

Drug selection is now widely viewed as an important and relatively new, yet largely unsolved, bottleneck in the drug discovery and development process. In order to achieve an efficient selection process, high quality, rapid, predictive and correlative ADME models are required in order for them to be confidently used to support critical financial decisions. Systems that can be relied upon to accurately predict performance in humans have not existed, and decisions have been made using tools whose capabilities could not be verified until candidates went to clinical trial, leading to the high failure rates historically observed. However, with the sequencing of the human genome, advances in proteomics, the anticipation of the identification of a vastly greater number of potential targets for drug discovery, and the potential of pharmacogenomics to require individualized evaluation of drug kinetics as well as drug effects, there is an urgent need for rapid and accurately computed pharmacokinetic properties.

References

Feb 1, 1991·Journal of Pharmacokinetics and Biopharmaceutics·A Bernareggi, M Rowland
Mar 1, 1988·British Journal of Clinical Pharmacology·R A PrentisS R Walker
Sep 1, 1971·Journal of Pharmaceutical Sciences·M GibaldiS Feldman
Nov 26, 1993·Science·J F BearyD E Wierenga
Apr 2, 1993·Science·P H Abelson
Jan 1, 1996·Journal of Pharmaceutical Sciences·K PalmP Artursson
Aug 6, 1998·Journal of Chemical Information and Computer Sciences·M D WesselS M Muskal
Oct 31, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G CamenischG Folkers
Mar 9, 1999·Bioinformatics·M TomitaC A Hutchison
Apr 3, 1999·Journal of Pharmaceutical Sciences·B H Stewart, O H Chan
Apr 24, 1999·Science·R F Service
May 11, 1999·Drug Discovery Today·D NobleW Scott
Sep 11, 1999·Drug Discovery Today·R Lahana
Sep 16, 1999·International Journal of Pharmaceutics·L X Yu, G L Amidon
Jan 27, 2000·Cell·R Brent
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·D A NorrisG M Grass
Mar 17, 2000·Science·J Drews
Mar 30, 2000·International Journal of Clinical Pharmacology and Therapeutics·A SeeligF Wohnsland
Apr 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S YamashitaH Tokuda
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·N H HolfordC C Peck
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·L P Balant, M Gex-Fabry
Jul 13, 2000·Journal of Medicinal Chemistry·F Yoshida, J G Topliss
Oct 7, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·L J LeskoB Stewart
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G CrucianiW Guba
Dec 29, 2000·Journal of Chemical Information and Computer Sciences·T Osterberg, U Norinder
Feb 15, 2001·Journal of Pharmaceutical Sciences·P PoulinF P Theil
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·S EkinsJ H Wikel

❮ Previous
Next ❯

Citations

Jul 29, 2010·Cell and Tissue Banking·Robert A Coleman
Sep 28, 2007·Journal of Pharmacokinetics and Pharmacodynamics·Max von Kleist, Wilhelm Huisinga
Dec 14, 2011·Journal of Pharmacokinetics and Pharmacodynamics·John F GrafMaria I Zavodszky
Aug 14, 2003·Trends in Pharmacological Sciences·Paul A Whittaker
Oct 3, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Neil Parrott, Thierry Lavé
Mar 11, 2011·SAR and QSAR in Environmental Research·T Peyret, K Krishnan
Dec 16, 2005·The AAPS Journal·Mark G Papich
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Florian NigschSilvia Miret
Mar 14, 2008·Clinical Pharmacokinetics·Michel TodGérard Pons
Sep 12, 2008·Clinical Pharmacokinetics·Jennifer B DressmanEkarat Jantratid
Nov 19, 2010·Bioanalysis·Stephen R DuekerJohn S Vogel
Sep 28, 2013·Pharmaceutical Research·Andrés Olivares-MoralesAmin Rostami-Hodjegan
Jan 4, 2012·Journal of Pharmaceutical Sciences·Ann NewmanGeorge Zografi
Mar 16, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Veronika RozehnalJuergen Mueller
Dec 22, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Martin KuentzDavid P Elder
Aug 28, 2009·The Veterinary Journal·Aneliya Milanova Haritova, Johanna Fink-Gremmels
Aug 26, 2015·Therapeutic Delivery·Riccardo Panicucci, Manuel Sanchez-Felix
May 15, 2012·Biopharmaceutics & Drug Disposition·Ryusuke TakanoShinji Yamashita
Feb 15, 2003·Journal of Pharmaceutical Sciences·Joseph V TurnerSnezana Agatonovic-Kustrin
Sep 2, 2005·Journal of Pharmaceutical Sciences·Neil ParrottThierry Lavé
Nov 22, 2007·Expert Opinion on Drug Metabolism & Toxicology·Stefan S De Buck, Claire E Mackie
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·David E Leahy
Dec 2, 2008·Expert Opinion on Drug Metabolism & Toxicology·Graham Lappin, R Colin Garner
Jan 3, 2013·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Tjerk BuetersJohan Bylund
Aug 31, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Helen MustherAmin Rostami Hodjegan
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Apr 6, 2005·The Journal of Pharmacy and Pharmacology·Hans Lennernäs, Bertil Abrahamsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.